Ajanta launches generic Kapvay
Ajanta Pharma has launched its generic of Concordia Pharmaceuticals’ Kapvay (clonidine hydrochloride) extended-release tablets. The Mumbai-based company’s launch of the product follows the Food and Drug Administration approving it on Tuesday.
The drug is indicated to treat attention deficit hyperactivity disorder as a monotherapy and as adjunctive treatment to stimulants. Ajanta’s generic will be available in 0.1-mg dosage strength.
CHPA recognizes Bayer for aspirin campaign
Bayer Aspirin has been named the recipient of the Consumer Healthcare Products Association 2017 Industry Leadership Award for Advancing Self-Care. This recognition comes from the New Jersey-based company’s “The HeroSmiths” marketing campaign, which was aimed to educate people of the life-saving benefits of aspirin during a suspected heart attack.
“Building a movement based on consumer needs and one that blends education with action is the epitome of advancing responsible self-care, and it’s an honor for us to be recognized,” Natalie Bartner, president of Bayer Consumer Health in North America, said. “The HeroSmiths campaign has the potential to quite literally save lives, and we’re proud that Bayer aspirin can help people become heroes.”
Each year the Consumer Healthcare Products Association (CPHA) awards one member in the company with the prestigious Industry Leadership Award for Advancing Responsible Self-Care, honoring the educational efforts that have created positive impact on the consumer healthcare industry.
According to a study done by the Second International Study of Infarct Survival Collaborative Group, during a suspected heart attack chewing aspirin as directed by a doctor can help increase chances of survival. The “HeroSmiths” program which launched back in Feb. 2007, brings awareness to this and carries the message of carrying aspirin everywhere in the event that someone nearby suffers from a heart attack.
Stericycle partners with National Safety Council to combat opioid crisis
Stericycle, a company focused on providing essential highly specialized compliance-based solutions has partnered with the National Safety Council. The Chicago-based company will be the exclusive medical disposal partner for the “Stop Everyday Killers” national education campaign addressing the opioid epidemic.
“Our nation is in the midst of the worst drug crisis in recorded history, but we know there are things we can do to save lives,” Deborah A.P. Hersman, president and CEO of the National Safety Council, said. “The campaign honors those who have been lost to this epidemic while also offering hope and empowering visitors to take action. One of the simplest things they can do is clean out their medicine cabinets, and Stericycle is making that much easier. We are proud to collaborate with them on this important issue.”
Launched in Chicago, the “Stop Everyday Killers” campaign unveiled the interactive art installation titled, Prescribed to Death: A Memorial to the Victims of the Opioid Crisis. A wall made of medicine pills, each individually carved with imaged of the 22,000 people who died within the last year due to prescription overdoses will be featured. Additionally, a new pill bearing a human face will be 3D printed on the site and added to the wall every 24 minutes to represent someone dying every 24 minutes from an opioid overdose.
“We are pleased to work with the National Safety Council on this incredible campaign and hope it will shine a light on our country’s opioid crisis as well as the options to help combat the problem,” Charles A. Alutto, president and chief executive officer of Stericycle said.
Stericycle will be providing complimentary Seal&Send medication disposal envelopes to everyone who visits the memorial to ease the process of returning unused pills. As part of the industry’s most comprehensive pharmaceutical disposal program, Stericycle’s Seal&Send Envelopes are a safe, reliable and anonymous method to easily mail unused medicines for disposal.